✦ LIBER ✦

An alternative approach for exercise prescription and efficacy testing in patients with chronic heart failure: A randomized controlled training study

✍ Scribed by Tim Meyer; Günter Görge; Bernhard Schwaab; Katharina Hildebrandt; Jens Walldorf; Christine Schäfer; Ingrid Kindermann; Jürgen Scharhag; Wilfried Kindermann

Book ID: 116190012
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 145 KB
Volume: 149
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2004.12.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II, Randomized, Double-Blind, Mu

A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart Failure

✍ Runlin Gao; Jian Zhang; Liuquan Cheng; Xuesi Wu; Wei Dong; Xinchun Yang; Tiancha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 798 KB

Effect of Long-Acting Testosterone Treat

Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Study

✍ Giuseppe Caminiti; Maurizio Volterrani; Ferdinando Iellamo; Giuseppe Marazzi; Ro 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Glycemia and prognosis of patients with

Glycemia and prognosis of patients with chronic heart failure—Subanalysis of the Long-term Prospective Randomized Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients (REMADHE) trial

✍ Victor S. Issa; Alexandre F. Amaral; Fátima D. Cruz; Silvia M. Ayub-Ferreira; Gu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 316 KB

A Single-Center, Open-Label, Randomized,

A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study

✍ Nobuo Totsuka; Nobuhisa Awata; Katsuhito Takahashi; Hisako Yamamura; Junko Nakam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A phase II, double-blind, randomized, pl

A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design

✍ Michael Zile; William Gaasch; William Little; Gary Francis; Luigi Tavazzi; John 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 108 KB